4,4-二苯基丁-3-烯-1-基胺 | 93007-58-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4,4-二苯基丁-3-烯-1-基胺
• 英文名称: 4,4-diphenylbut-3-en-1-amine
• 英文别名: 4,4-diphenyl-3-butenylamine
• CAS: 93007-58-0
• 化学式: C₁₆H₁₇N
• 分子量: 223.318
• InChiKey: LXOFBDVFIUUFNZ-UHFFFAOYSA-N

物化性质

• 沸点：
  157-160 °C(Press: 5 Torr)
• 密度：
  1.028±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  17
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  4,4-二苯基丁-3-烯-1-基胺 在 三乙基硅烷 、 三氟乙酸 作用下， 以 甲醇 为溶剂， 反应 6.0h， 生成 ((1-cyclohexyl-1H-tetrazol-5-yl)methyl)-(4,4-diphenylbutyl)amine
  参考文献：
  名称：

  氨基甲基四唑类化合物作为潜在的γ-氨基丁酸转运蛋白mGAT1–mGAT4的抑制剂：合成与生物学评估

  摘要：

  以Ugi反应的TMSN 3修饰的变体为关键步骤，合成了衍生自甘氨酸的1，5-二取代和5-单取代的氨基甲基四唑衍生物。对所有化合物在四种鼠类GABA转运蛋白亚型mGAT1–mGAT4上的抑制力和亚型选择性进行了评估。尽管没有5取代的四唑类化合物能抑制[ 3H] GABA的吸收程度很高，1，5-二取代的四唑衍生物表现出独特的活性，尤其是在GABA转运蛋白mGAT2-mGAT4处。因此，发现了合理的有效和选择性的mGAT3抑制剂。另外，鉴定出另外两种化合物是mGAT2的有效抑制剂。这是特别相关的，因为到目前为止，只有很少几种不影响mGAT1的有效mGAT2抑制剂是已知的。

  DOI：

  10.1016/j.bmc.2011.08.039
• 作为产物：
  描述：

  4,4-二苯基丁-3-烯-1-醇 在 四丁基溴化铵 、 氢溴酸 、 一水合肼 作用下， 以 乙醇 、 N,N-二甲基甲酰胺 为溶剂， 反应 36.67h， 生成 4,4-二苯基丁-3-烯-1-基胺
  参考文献：
  名称：

  使用丙二酰过氧化物进行烯烃氧化：吡咯烷和异恶唑烷的制备

  摘要：

  高烯丙基的治疗Ñ甲苯磺酰胺或烯丙基ñ -tosyl用的过氧化物malonoyl 1.5当量羟胺提供一种立体选择性的方法来访问官能吡咯烷和异恶唑烷。这种无金属的烯烃氧胺化反应收率可达50-85％，反式选择性高达13：1 。另外，氧和氮取代基的相对立体化学可以通过氧化/还原序列或起始烯烃的立体化学来反转。机理研究表明，羟基亲核试剂比磺酰胺亲核试剂具有更高的反应性，表明对双加氧反应的偏好高于对氧胺的反应。

  DOI：

  10.1021/acs.joc.8b00392

文献信息

• Palladium(II)-Catalyzed Regioselective syn-Hydroarylation of Disubstituted Alkynes Using a Removable Directing Group
  作者：Zhen Liu、Joseph Derosa、Keary M. Engle

  DOI：10.1021/jacs.6b08818

  日期：2016.10.5

  A palladium(II)-catalyzed regioselective syn-hydroarylation reaction of homopropargyl amines has been developed, wherein selectivity is controlled by a cleavable bidentate directing group. Under the optimized reaction conditions, both dialkyl and alkylaryl alkyne substrates were found to undergo hydroarylation with high selectivity. The products of this reaction contain a 4,4-disubstituted homoallylic

  已经开发了钯 (II) 催化的高炔丙基胺的区域选择性顺氢芳基化反应，其中选择性由可裂解的双齿导向基团控制。在优化的反应条件下，发现二烷基和烷芳基炔底物均以高选择性进行加氢芳基化。该反应的产物含有 4,4-二取代的高烯丙基胺基序，这在药物分子和其他生物活性化合物中很常见。
• Brønsted Acid-Initiated Formal [1,3]-Rearrangement Dictated by β-Substituted Ene-Aldimines
  作者：Chanantida Jongwohan、Yasushi Honda、Toshiyasu Suzuki、Takeshi Fujinami、Kiyohiro Adachi、Norie Momiyama

  DOI：10.1021/acs.orglett.9b01533

  日期：2019.7.5

  ene-aldimines is a useful reaction for affording homoallylic amines. Despite their utilities in synthetic chemistry, the rearrangement for accessing homoallylic amines substituted at the 2-position remains elusive. In this study, the Brønsted acid-initiated formal [1,3]-rearrangement of ene-aldimines was developed to synthesize 2,4,4-substituted homoallylic amines that were otherwise inaccessible previously

  烯丙二胺的重排是用于提供均烯丙基胺的有用反应。尽管它们在合成化学中有用，但仍难以获得在2-位取代的均烯丙基胺的重排。在这项研究中，开发了由Brønsted酸引发的烯丙二胺的正式[1,3]重排，以合成2,4,4-取代的均烯丙基胺，而这在以前是无法获得的。我们的研究揭示了一个分子间途径，其中重排通过质子化介导的2-氮杂铝阳离子进行。
• 2-Substituted 4-hydroxybutanamides as potential inhibitors of γ-aminobutyric acid transporters mGAT1–mGAT4: Synthesis and biological evaluation
  作者：Paula Kowalczyk、Kinga Sałat、Georg C. Höfner、Natalia Guzior、Barbara Filipek、Klaus T. Wanner、Katarzyna Kulig

  DOI：10.1016/j.bmc.2013.06.038

  日期：2013.9

  A series of 2-substituted 4-hydroxybutanamide derivatives has been synthesized by the aminolysis of appropriate 2-substituted dihydrofuran-2(3H)-one derivatives with various substituted benzylamines. The final compounds have been evaluated for their capability of inhibiting the GABA transport proteins GAT1-4 stably expressed in HEK-239 cell lines. The pIC50 values determined were in the range 4.21–5

  通过适当的2-取代的二氢呋喃-2（3H）-one衍生物与各种取代的苄胺的氨解，已经合成了一系列的2-取代的4-羟基丁酰胺衍生物。已经评估了最终化合物抑制在HEK-239细胞系中稳定表达的GABA转运蛋白GAT1-4的能力。在PIC 50确定的值分别在范围4.21-5.14。两种化合物（16a和16d）在体外测试中表现出最有趣的特性，也已经进行了进一步的初步行为研究，评估了它们在热板，扭体和福尔马林测试中的抗伤害感受活性。还评估了它们对运动协调的影响。
• Synthesis, biological evaluation and structure–activity relationship of new GABA uptake inhibitors, derivatives of 4-aminobutanamides
  作者：Paula Kowalczyk、Kinga Sałat、Georg C. Höfner、Marta Mucha、Anna Rapacz、Adrian Podkowa、Barbara Filipek、Klaus T. Wanner、Katarzyna Kulig

  DOI：10.1016/j.ejmech.2014.06.024

  日期：2014.8

  Six series of 2-substituted 4-aminobutanamide derivatives were synthesized and evaluated for their ability to inhibit GABA transport proteins mGAT1-4 stably expressed in HEK-293 cell lines. The pIC50 values determined were in the range 4.23-5.23. Two compounds (15b and 15c) were selected for further in vitro studies. These compounds were also subjected to preliminary behavioral studies to evaluate their anticonvulsant, antidepressant-like, and antinociceptive activities in mice. Their influence on motor coordination was also assessed. We report that, among a spectrum of in vivo activities, both 15b and 15c displayed significant activity against pentylenetetrazole (PTZ)-induced seizures.
• Orally Active and Potent Inhibitors of γ-Aminobutyric Acid Uptake
  作者：Fadia E. Ali、William E. Bondinell、Penelope A. Dandridge、James S. Frazee、Eleanor Garvey、Gerald R. Girard、Carl Kaiser、Thomas W. Ku、John J. Lafferty、George I. Moonsammy、Hye-Ja Oh、Julia A. Rush、Paulette E. Setler、Orum D. Stringer、Joseph W. Venslavsky、Beth W. Volpe、Libby M. Yunger、Charles L. Zirkle

  DOI：10.1021/jm50001a020

  日期：1985.5

  3-Pyrrolidineacetic acid (1a), certain piperidinecarboxylic acids--i.e., 3-piperidinecarboxylic acid (2a), 1,2,5,6-tetrahydro-3-pyridinecarboxylic acid (3a), and cis-4-hydroxy-3-piperidinecarboxylic acid (4a)--cis-3-aminocyclohexanecarboxylic acid (5a, cis-3-ACHC), and gamma-aminobutyric acid (6a, GABA) itself are among the most potent inhibitors of [3H]GABA uptake by neurons and glia in vitro. These hydrophilic amino acids, however, do not readily enter the central nervous system in pharmacologically significant amounts following peripheral administration. We now report that N-(4,4-diphenyl-3-butenyl)-3-piperidinecarboxylic acid (2b) is a specific GABA-uptake inhibitor that is more potent, more lipophilic and, in limited testing, as selective as 2a. Similar results were obtained with the N-(4,4-diphenyl-3-butenyl) derivatives of 1a, 3a, and 4a. By contrast, N-(4,4-diphenyl-3-butenyl) derivatives of 5a and 6a were not more potent than the parent amino acids and appear to inhibit GABA uptake, at least in part, by a nonselective mechanism of action. The N-(4,4-diphenyl-3-butenyl)amino acids 1b-4b exhibit anticonvulsant activity in rodents following oral or intraperitoneal administration [Yunger, L.M.; et al. J. Pharmacol. Exp. Ther. 1984, 228, 109].